4-[4-(Piperidine-1-sulfonyl)phenoxy]-3-(trifluoromethyl)aniline

Catalog No.: 
ACXVHH187
CAS No.: 
1858252-16-0
Molecular Formula: 
C18H19F3N2O3S
Molecular Weight: 
400.42
4-[4-(Piperidine-1-sulfonyl)phenoxy]-3-(trifluoromethyl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$282.00InquiryInquiry
1g90%$875.00InquiryInquiry
5g90%$4288.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[4-(Piperidine-1-sulfonyl)phenoxy]-3-(trifluoromethyl)aniline
IUPAC Name4-(4-(piperidin-1-ylsulfonyl)phenoxy)-3-(trifluoromethyl)aniline
Molecular FormulaC18H19F3N2O3S
Molecular Weight400.42
SMILESNC1=CC=C(OC2=CC=C(S(=O)(N3CCCCC3)=O)C=C2)C(C(F)(F)F)=C1
InChI KeyADYOROMZXIDULD-UHFFFAOYSA-N
Synonym4-[4-(Piperidin-1-ylsulfonyl)phenoxy]-3-(trifluoromethyl)aniline;4-[4-(piperidine-1-sulfonyl)phenoxy]-3-(trifluoromethyl)aniline;Benzenamine, 4-[4-(1-piperidinylsulfonyl)phenoxy]-3-(trifluoromethyl)-
CAS No.1858252-16-0

Synthetic Route by SureRoute

1. ACXVHH187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADOL146 route compound structure diagram
    ACADOL1461535-76-8In Stock
  2. Plus
  3. ACUWJC539 route compound structure diagram
    ACUWJC539834-66-2In Stock
  4. Then
  5. ACXVHH187 route product structure diagram
    ACXVHH1871858252-16-0
Inquiry

2. ACXVHH187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADOL146 route compound structure diagram
    ACADOL1461535-76-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXVHH187 route product structure diagram
    ACXVHH1871858252-16-0
Inquiry

3. ACXVHH187 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXVHH187 route product structure diagram
    ACXVHH1871858252-16-0
Inquiry

Comments (0)